Literature DB >> 30760508

Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach.

Calvin C Daniels1, Jonathan D Burlison2, Donald K Baker3, Jennifer Robertson2, Andras Sablauer3,4, Patricia M Flynn5,6, Patrick K Campbell3,7, James M Hoffman2,5.   

Abstract

OBJECTIVES: Excessive alerts are a common concern associated with clinical decision support systems that monitor drug-drug interactions (DDIs). To reduce the number of low-value interruptive DDI alerts at our hospital, we implemented an iterative, multidimensional quality improvement effort, which included an interdisciplinary advisory group, alert metrics, and measurement of perceived clinical value.
METHODS: Alert data analysis indicated that DDIs were the most common interruptive medication alert. An interdisciplinary alert advisory group was formed to provide expert advice and oversight for alert refinement and ongoing review of alert data. Alert data were categorized into drug classes and analyzed to identify DDI alerts for refinement. Refinement strategies included alert suppression and modification of alerts to be contextually aware.
RESULTS: On the basis of historical analysis of classified DDI alerts, 26 alert refinements were implemented, representing 47% of all alerts. Alert refinement efforts resulted in the following substantial decreases in the number of interruptive DDI alerts: 40% for all clinicians (22.9-14 per 100 orders) and as high as 82% for attending physicians (6.5-1.2 per 100 orders). Two patient safety events related to alert refinements were reported during the project period.
CONCLUSIONS: Our quality improvement effort refined 47% of all DDI alerts that were firing during historical analysis, significantly reduced the number of DDI alerts in a 54-week period, and established a model for sustained alert refinements.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2019        PMID: 30760508      PMCID: PMC6398362          DOI: 10.1542/peds.2017-4111

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.

Authors:  Heba Edrees; Mary G Amato; Adrian Wong; Diane L Seger; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

2.  The potential for leveraging machine learning to filter medication alerts.

Authors:  Siru Liu; Kensaku Kawamoto; Guilherme Del Fiol; Charlene Weir; Daniel C Malone; Thomas J Reese; Keaton Morgan; David ElHalta; Samir Abdelrahman
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

3.  Designing and evaluating contextualized drug-drug interaction algorithms.

Authors:  Eric Chou; Richard D Boyce; Baran Balkan; Vignesh Subbian; Andrew Romero; Philip D Hansten; John R Horn; Sheila Gephart; Daniel C Malone
Journal:  JAMIA Open       Date:  2021-03-19

4.  A Minimal Information Model for Potential Drug-Drug Interactions.

Authors:  Harry Hochheiser; Xia Jing; Elizabeth A Garcia; Serkan Ayvaz; Ratnesh Sahay; Michel Dumontier; Juan M Banda; Oya Beyan; Mathias Brochhausen; Evan Draper; Sam Habiel; Oktie Hassanzadeh; Maria Herrero-Zazo; Brian Hocum; John Horn; Brian LeBaron; Daniel C Malone; Øystein Nytrø; Thomas Reese; Katrina Romagnoli; Jodi Schneider; Louisa Yu Zhang; Richard D Boyce
Journal:  Front Pharmacol       Date:  2021-03-08       Impact factor: 5.810

5.  Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients.

Authors:  Arthur T M Wasylewicz; Britt W M van de Burgt; Thomas Manten; Marieke Kerskes; Wilma N Compagner; Erik H M Korsten; Toine C G Egberts; Rene J E Grouls
Journal:  Clin Pharmacol Ther       Date:  2022-06-27       Impact factor: 6.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.